These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10411168)

  • 21. Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.
    Doukaki S; Pistone G; Aricò M; Bongiorno MR
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):237-44. PubMed ID: 21192770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab.
    Yeo PM; Ang CC
    Ann Acad Med Singap; 2017 Aug; 46(8):329-330. PubMed ID: 28920136
    [No Abstract]   [Full Text] [Related]  

  • 23. Pemphigus foliaceus in an adolescent.
    Adah A; Hill K; Wyatt J; Didion L
    J Pediatr; 2014 Nov; 165(5):1062.e1. PubMed ID: 25151193
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
    Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized Kaposi's sarcoma in a patient with pemphigus vulgaris.
    Avalos-Peralta P; Herrera A; Ríos-Martín JJ; Pérez-Bernal AM; Moreno-Ramírez D; Camacho F
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):79-83. PubMed ID: 16405614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
    Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
    J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycophenolate mofetil.
    Zwerner J; Fiorentino D
    Dermatol Ther; 2007; 20(4):229-38. PubMed ID: 17970888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris.
    Hopkins ZH; Wu BC; Nousari CH
    N Engl J Med; 2021 Sep; 385(11):1055-1056. PubMed ID: 34496187
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate mofetil in the treatment of childhood pemphigus vulgaris.
    Antonucci R; Locci C; Biondi G; Manconi A; Mannazzu R; Abis L; Sucato F; Satta R; Lissia A; Montesu MA
    Pediatr Int; 2020 Sep; 62(9):1123-1124. PubMed ID: 33000568
    [No Abstract]   [Full Text] [Related]  

  • 31. Rituximab versus Mycophenolate Mofetil in Pemphigus Vulgaris. Reply.
    Werth VP; Joly P; Chen DM
    N Engl J Med; 2021 Sep; 385(11):1056. PubMed ID: 34496188
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case reports: nodular vasculitis responsive to mycophenolate mofetil.
    Taverna JA; Radfar A; Pentland A; Poggioli G; Demierre MF
    J Drugs Dermatol; 2006; 5(10):992-3. PubMed ID: 17373149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of mycophenolate mofetil as a steroid-sparing agent in pemphigus: a randomized, prospective study.
    Ioannides D; Apalla Z; Lazaridou E; Rigopoulos D
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):855-60. PubMed ID: 21752101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [IgA pemphigus. Successful treatment with mycophenolate mofetil].
    Burchardt T; Büchau A; Ruzicka T; Megahed M
    Hautarzt; 2004 Apr; 55(4):387-9. PubMed ID: 15021936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
    Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Open trial of mycophenolate mofetil in the treatment of resistant pemphigus vulgaris].
    Chams-Davatchi C; Nonahal Azar R; Daneshpazooh M; Valikhani M; Hallaji Z; Barzegari M; Firouz AR; Zakeri M
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):23-5. PubMed ID: 11937925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
    Scheinfeld N
    J Dermatolog Treat; 2007; 18(4):243-5. PubMed ID: 17671884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil.
    Mimouni D; Anhalt GJ; Cummins DL; Kouba DJ; Thorne JE; Nousari HC
    Arch Dermatol; 2003 Jun; 139(6):739-42. PubMed ID: 12810504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.